Our group demonstrated that blocking the transcriptional activity of STAT3α by STAT3 isoform STAT3β sensitized esophageal squamous cell carcinoma (ESCC) cells to chemotherapeutic agents, namely, cisplatin and 5-FU both in vitro and in vivo [96]. The gene discussed is STAT3; the disease is esophageal squamous cell carcinoma.